This topic contains a solution. Click here to go to the answer

Author Question: The client who has received intravenous immune globulin must wait what length of time before ... (Read 107 times)

tingc95

  • Hero Member
  • *****
  • Posts: 556
The client who has received intravenous immune globulin must wait what length of time before receiving active immunization?
 
  1. 2 months
  2. 1 year
  3. 4 months
  4. 1 month

Question 2

The nurse correctly understands that the administration of the PCV vaccine should occur at which ages?
 
  1. 5 and 10 months
  2. 15 and 18 months
  3. 1, 8, 13, and 18 to 20 months
  4. 2, 4, 6, and 12 to 15 months



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

bhavsar

  • Sr. Member
  • ****
  • Posts: 351
Answer to Question 1

Correct Answer: 3
Rationale 1: Two months is not long enough.
Rationale 2: One year is too long to wait for additional immunizations.
Rationale 3: The client must wait at least 3 to 5 months.
Rationale 4: One month is not long enough.
Global Rationale: Because this drug contains antibodies to live viruses, active vaccinations should not be given until 3 to 5 months after IVIG has been administered.

Answer to Question 2

Correct Answer: 4
Rationale 1: This is not the time frame for PCV administration.
Rationale 2: This is not the time frame for PCV administration.
Rationale 3: This is not the time frame for PCV administration.
Rationale 4: The PCV vaccine should be administered at 2, 4, 6, and 12 to 15 months.
Global Rationale: Because the administration of PPV to young children with immature immune systems leads to a poor antibody response, this vaccine is not recommended in children under 2 years of age. A second vaccine, called pneumococcal conjugate vaccine (PCV), was specially developed for routine immunization in children under the age of 2. This immunization differs from PPV in that the S. pneumoniae polysaccharides are coupled with a protein that leads to improved immune activation in infants with immature immune function. The latest form of the pneumococcal conjugate vaccine, PCV13, was approved in 2010 and protects against 13 types of pneumococcal bacteria. PCV13 is used in a series of four IM injections at 2 months, 4 months, 6 months, and 12 to 15 months.




tingc95

  • Member
  • Posts: 556
Reply 2 on: Jul 23, 2018
YES! Correct, THANKS for helping me on my review


mohan

  • Member
  • Posts: 362
Reply 3 on: Yesterday
Excellent

 

Did you know?

Stroke kills people from all ethnic backgrounds, but the people at highest risk for fatal strokes are: black men, black women, Asian men, white men, and white women.

Did you know?

As many as 28% of hospitalized patients requiring mechanical ventilators to help them breathe (for more than 48 hours) will develop ventilator-associated pneumonia. Current therapy involves intravenous antibiotics, but new antibiotics that can be inhaled (and more directly treat the infection) are being developed.

Did you know?

The average human gut is home to perhaps 500 to 1,000 different species of bacteria.

Did you know?

In inpatient settings, adverse drug events account for an estimated one in three of all hospital adverse events. They affect approximately 2 million hospital stays every year, and prolong hospital stays by between one and five days.

Did you know?

The familiar sounds of your heart are made by the heart's valves as they open and close.

For a complete list of videos, visit our video library